PADAGIS ANNOUNCES FDA APPROVAL AND LAUNCH OF A-RATED GENERIC VERSION OF UCERIS® (BUDESONIDE 2MG RECTAL FOAM) ...Middle East

PR Newswire - News
PADAGIS ANNOUNCES FDA APPROVAL AND LAUNCH OF A-RATED GENERIC VERSION OF UCERIS® (BUDESONIDE 2MG RECTAL FOAM)
ALLEGAN, Mich., April 28, 2023 /PRNewswire/ -- Padagis today announced the launch of Budesonide 2mg Rectal Foam (generic to Uceris®) with 180-days of Competitive Generic Therapy exclusivity. Uceris® is a prescription corticosteroid medicine used to help get active, mild to moderate...

Hence then, the article about padagis announces fda approval and launch of a rated generic version of uceris budesonide 2mg rectal foam was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PADAGIS ANNOUNCES FDA APPROVAL AND LAUNCH OF A-RATED GENERIC VERSION OF UCERIS® (BUDESONIDE 2MG RECTAL FOAM) )

Apple Storegoogle play

Last updated :

Also on site :



Latest News